FINNENCE ▪ THE WIRE FILE
THE WIRE · № 71558
Company■ Unclear/unknown
Phase 3 results posted: A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems — Bayer
KINDCompany
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-08 12:00 UTC
LAST UPDATE2026-10-08 12:00 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Bayer's contrast agent Phase 3 results post, informing its MRI imaging franchise outlook.
Contrast agent data lands for Bayer's imaging pipeline
CATALYST TO WATCH
Regulatory submission and label decision
MAIN RISK
Safety or efficacy data disappoints reviewers
FULL DISPATCH
Sponsor: Bayer; Status: Completed; Conditions: Contrast Enhancement in Magnetic Resonance Imaging, Central Nervous System Pathology; Interventions: Gadoquatrane (BAY1747846), Gadobutrol, Gadoterate meglumine; Enrollment: 321 (actual); First posted: 2023-06-23; Results posted: 2026-10-08; NCT: NCT05915702
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Phase 3 results posted: Safety Study of Viaskin Peanut to Treat Peanut Allergy — DBV Technologies2026-10-08 12:00 UTC
Phase 3 results posted: Safety Study of Viaskin Peanut to Treat Peanut Allergy — DBV Technologies2026-10-08 12:00 UTC
→CORRELATIONshares Healthcare
Telix Pharmaceuticals: Merger Bodes Well For Long-Term Plan (NASDAQ:TLX)2026-10-08 15:31 UTC
Telix Pharmaceuticals: Merger Bodes Well For Long-Term Plan (NASDAQ:TLX)2026-10-08 15:31 UTC
→CORRELATIONshares Healthcare
Apodex Opens Free AI Computing Services to Accelerate Drug Research2026-10-08 17:25 UTC
Apodex Opens Free AI Computing Services to Accelerate Drug Research2026-10-08 17:25 UTC
→CORRELATIONshares Healthcare
WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules2026-10-08 17:30 UTC
WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules2026-10-08 17:30 UTC
→CORRELATIONshares Healthcare
Phenomenex Introduces Strata-Mag RP to Enable Automated LC-MS/MS Sample Preparation at Scale2026-10-08 17:45 UTC
Phenomenex Introduces Strata-Mag RP to Enable Automated LC-MS/MS Sample Preparation at Scale2026-10-08 17:45 UTC
→CORRELATIONshares Healthcare
Human Milk Offers a Window Into Mammary Gland Function--and Its Links to Infant Growth2026-10-08 18:00 UTC
Human Milk Offers a Window Into Mammary Gland Function--and Its Links to Infant Growth2026-10-08 18:00 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.